What’s more, the positive or negative regulatory relationship among CELF5, splicing isoforms of GSG1L, primary bile acid synthesis signaling pathway, and GBM tumorigenesis will be validated by biological function assays like gain/loss of function and rescue assays. This evidence concerns the gene CELF5 and glioblastoma.